Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BIOENVISION INC (BIVN)
|
Add to portfolio |
|
|
|
| Price: |
$5.45
| | Metrics |
| OS: |
45.3
|
M
| |
|
|
| Market cap: |
$247
|
M
| |
|
|
|
Net cash:
|
$49.2
|
M
| |
$1.09
|
per share
|
|
EV:
|
$198
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jun-30-07 | Jun-30-06 | Jun-30-05 |
| Revenues | 19.1 | 5.3 | 4.7 |
| Revenue growth | 259.2% | 14.1% | |
| Cost of goods sold | 3.5 | 1.7 | 0.9 |
| Gross profit | 15.6 | 3.6 | 3.7 |
| Gross margin | 81.9% | 68.7% | 80.2% |
| Selling, general and administrative | 27.7 | 16.6 | 10.2 |
| Research and development | 21.1 | 11.7 | 10.9 |
| EBIT | -34.3 | -25.6 | -19.7 |
| EBIT margin | -180.0% | -483.0% | -422.6% |
| Pre-tax income | -35.9 | -23.9 | -24.3 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% |
| Net income | -36.2 | -24.2 | -24.7 |
| Net margin | -190.1% | -456.5% | -530.3% |
| |
| Diluted EPS | ($0.80) | ($0.59) | ($0.72) |
| Shares outstanding (diluted) | 45.3 | 41.1 | 34.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|